Skip to content
Back to Guavy Wire
Stocks

P&G Bolsters Health and Wellness Portfolio with $3.8B Thorne Acquisition

Instruments
PG
Share

Procter & Gamble (P&G) has made a bold move into the booming health and wellness space by acquiring supplements maker Thorne for $3.8 billion in cash.

The deal, announced Tuesday, marks one of the consumer goods sector's most striking deals this year as legacy household-name companies scramble to plant their flags in the growing market.

P&G's existing supplements lineup includes New Chapter, Metamucil, and Align Probiotic, but just last week the company forecast slower annual sales growth overall, even as its beauty and wellness division posted strong results.

Jay Woods, chief market strategist at Freedom Capital Markets, framed the deal as a strategic pivot toward a market with far more horsepower than P&G's traditional household staples.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Real-time market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc